Effects of tenidap on the progression of osteoarthritic lesions in a canine experimental model: Suppression of metalloprotease and interleukin-1 activity

Arthritis and Rheumatism

Volumn 40, Issue 2, 1997, Pages 284-294

  Fernandes, Julio C ^a   Caron, John P ^b   Martel Pelletier, Johanne ^c   Jovanovic, Dragan ^a   Mineau, François ^a   Tardif, Ginette ^c,d   Otterness, Ivan G ^e   Pelletier, Jean Pierre ^b,c  

^a Osteoarthritis Research Unit   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; METALLOPROTEINASE; OMEPRAZOLE; TENIDAP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOG; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL MODEL; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARTILAGE, ARTICULAR; COLLAGENASES; DISEASE MODELS, ANIMAL; DOGS; GELATINASES; GENE EXPRESSION; INDOLES; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 3; METALLOENDOPEPTIDASES; OSTEOARTHRITIS; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 0031058583     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400213     Document Type: Article

References (43)

1. Pelletier JP, Martel-Pelletier J, Howell DS: Etiopathogenesis of osteoarthritis. In, Arthritis and Allied Conditions: A Textbook of Rheumatology. Thirteenth edition. Edited by WJ Koopman. Philadelphia, Lea & Febiger, 1996
2. Raiss RX, Karbowski A, Aigner T, Schleyerbach R: Chondrocytes and antirheumatic drugs. J Rheumatol 22 (suppl 43):152-154, 1995
3. Schumacher HR Jr: Synovial inflammation, crystals, and osteoarthritis. J Rheumatol 22:101-103, 1995
4. Pelletier JP, DiBattista JA, Roughley P, McCollum R, Martel-Pelletier J: Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am 1993
5. Dieppe P: Therapeutic targets in osteoarthritis. J Rheumatol 22:136-139, 1995
6. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J: The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: a role in osteoarthritis. J Clin Invest 97:2011-2019, 1996
7. Dean DD: Proteinase-mediated cartilage degradation in osteoarthritis. Semin Arthritis Rheum 20:2-11, 1991
8. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP: Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 70:807-815, 1994
9. Lohmander LS, Hoerrner LA, Lark MW: Metalloproteinases, tissue inhibitor and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 36:181-189, 1993
10. Martel-Pelletier J, Faure MP, McCoilum R, Cloutier JM, Pelletier JP: Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage. J Rheumatol 18:1863-1871, 1991
11. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF Jr: Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84:678-685, 1989
12. Brandt KD: Insights into the natural history of osteoarthritis provided by the cruciate-deficient dog: an animal model of osteoarthritis. Ann N Y Acad Sci 732:199-205, 1994
13. Adams ME, Pelletier JP: Canine anterior cruciate ligament transection model of osteoarthritis. In, CRC Handbook of Animal Models for the Rheumatic Diseases. Volume II. Edited by RA Greenwald, HS Diamond. Boca Raton, FL, CRC Press Inc., 1990
14. Pelletier JP, DiBattista JA, Raynauld JP, Wilhelm S, Martel-Pelletier J: The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1 and oncogene protein synthesis in experimental osteoarthritis. Lab Invest 72:578-586, 1995
15. Pelletier J-P, Mineau F, Raynauld J-P, Woessner JF Jr, Gunja-Smith Z, Martel-Pelletier J: Intraarticular injections with methyl-prednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 37:414-423, 1994
16. Yu LP Jr, Smith GN Jr, Brandt KD, Myers SL, O'Connor BL, Brandt DA: Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 35:1150-1159, 1992
17. Moore PF, Larson DL, Otterness IG, Weissman A, Kadin SB, Sweeney FJ, Eskra JD, Nagahisa A, Sakakibar M, Carty TJ: Tenidap, a structurally novel drug for the treatment of arthritis: antiinflammatory and analgesic activity. Inflamm Res (in press)
18. Otterness IG, Carty TJ, Loose LD: Tenidap: a new drug for arthritis. In, Therapeutic Approaches to Inflammatory Diseases. Edited by AJ Lewis, NS Doherty, NR Ackerman. New York, Elsevier, 1989
19. Sipe JD, Bartle LM, Loose LD: Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen: a possible correlate with clinical acute phase response. J Immunol 148:480-484, 1992
20. Ounissi-Benkalha H, Pelletier JP, Tardif G, Mineau F, Jolicoeur FC, Ranger P, Martel-Pelletier J: In vitro effects of 2 antirheu- matic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis. J Rheumatol 23:16-23, 1996
21. Fernandes JC, Martel-Pelletier J, Otterness IG, Lopez-Anaya A, Mineau F, Tardif G, Pelletier J-P: Effects of tenidap on canine experimental osteoarthritis. I. Morphologic and metalloprotease analysis. Arthritis Rheum 38:1290-1303, 1995
22. Pelletier J-P, McCollum R, DiBattista J, Loose LD, Cloutier J-M, Martel-Pelletier J: Regulation of human normal and osteoarthritic chondrocyte interleukin-1 receptor by antirheumatic drugs. Arthritis Rheum 36:1517-1527, 1993
23. Davis JS, Loose L, Borger AP: Clinical efficacy of CP-66, 248 [5-chloro-2,3-dihydro-2-oxo-3-(2-thienylcarbonyl)-indole-1-carboxamide] in osteoarthritis (abstract). Arthritis Rheum 31 (suppl 4):S72, 1993
24. Caldwell JR, Kirby DS, Gardner MJ, Hansen RA: The effects of age and gender on the pharmacokinetics of tenidap sodium in patients with rheumatoid arthritis and osteoarthritis. Br J Clin Pharmacol 39:3S-9S, 1995
25. Mankin HJ, Dorfman H, Lippiello L, Zarins A: Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg [Am] 53:523-537, 1971
26. 3H] acetylated collagen. Anal Biochem 148:174-181, 1985
27. Chavira R Jr, Burnett TJ, Hageman JH: Assaying proteinases with azocoll. Anal Biochem 136:446-450, 1984
28. Harris ED Jr, Krane SM: An endopeptidase from rheumatoid synovial tissue culture. Biochim Biophys Acta 258:566-576, 1972
29. Bhardwaj N, Lau LL, Rivelis M, Steinman RM: Interleukin-1 production by mononuclear cells from rheumatoid synovial effusions. Cell Immunol 114:405-423, 1988
30. Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Toliva J, Lopez-Otin C: Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269:16766-16773, 1994
31. Saus J, Quinones S, Otani Y, Nagase H, Harris ED Jr, Kurkinen M: The complete primary structure of human matrix metalloproteinase-3: identity with stromelysin. J Biol Chem 263:6742-6745, 1988
32. Arend WP: Growth factors and cytokines in the rheumatic diseases. In, Primer on the Rheumatic Diseases. Tenth edition. Edited by HR Schumacher Jr, JH Kuppel, WJ Koopman. Atlanta, Arthritis Foundation, 1993
33. Van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB: Transforming growth factor-β1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 71:279-290, 1994
34. Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G, Mineau F, Geng C, Pelletier J-P: Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: suppression of collagenase-1 expression. Arthritis Rheum 39:1535-1544, 1996
35. Vivien D, Galera P, Lebrun E, Loyau G, Pujol JP: Differential effects of transforming growth factor-beta and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes. J Cell Physiol 143:534-545, 1990
36. Trippel SB: Growth factors actions on articular cartilage. J Rheumatol 22 (suppl 43):129-132, 1995
37. Vivien D, Boumedienne K, Galera P, LeBrun E, Loyau G, Pujol JP: Flow cytometric detection of transforming growth factor-β expression in rabbit articular chondrocytes (RAC) in culture association with S-phase traverse. Exp Cell Res 203:56-61, 1992
38. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM: Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A 87:9843-9847, 1990
39. Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K: Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun 174:96-101, 1991
40. MacNaul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI: Discoordinate expression of stromelysin, collagenase and tissue inhibitor of metalloproteinase-1 in rheumatoid human synovial fibroblasts: synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem 265:17238-17245, 1990
41. Knäuper V, López-Otin C, Smith B, Knight G, Murphy G: Biochemical characterization of human collagenase-3. J Biol Chem 271:1544-1550, 1996
42. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJ: Stromelysin is an activator of procollagenase; a study with natural and recombinant enzymes. Biochem J 248:265-268, 1987
43. Lotz M, Blanco FJ, von Kempis J, Dudler J, Maier R, Villiger PM, Geng Y: Cytokine regulation of chondrocyte functions. J Rheumatol 22 (suppl 43):104-108, 1995